We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 203.21%
This Fund
S&P 500
This Quarter Est. Return
+16.51%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$1.31B
AUM Growth
+$63.1M
Cap. Flow
+$10.4M
Cap. Flow %
0.8%
Top 10 Hldgs %
44.12%
Holding
87
New
12
Increased
18
Reduced
18
Closed
37

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$36.9M
2
IRTC icon
iRhythm Holdings
IRTC
+$30.2M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$28.4M
4
PODD icon
Insulet
PODD
+$28.2M
5
PRVA icon
Privia Health
PRVA
+$23.3M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$90.9M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$19.8M
3
PRTA icon
Prothena Corp
PRTA
+$19.2M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$17.9M
5
MODN
MODEL N, INC.
MODN
+$17.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.53%
2 Industrials 2.52%
3 Communication Services 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX
1
DELISTED
Crinetics Pharmaceuticals
CRNX
$79.1M 6.06%
1,690,177
-297,595
-15% -$11.6M
ATEC icon
2
Alphatec Holdings
ATEC
$1.65B
$74.7M 5.72%
5,418,631
-558,220
-9% -$8.28M
NTRA icon
3
Natera
NTRA
$50.6B
$60.1M 4.6%
656,708
+490,822
+296% +$36.9M
XENE icon
4
Xenon Pharmaceuticals
XENE
$5.45B
$56.8M 4.35%
1,320,172
-325,318
-20% -$15M
PLRX icon
5
Pliant Therapeutics
PLRX
$69.4M
$52.7M 4.03%
3,534,993
-56,783
-2% -$937K
TMDX icon
6
Transmedics
TMDX
$3.05B
$52.6M 4.03%
711,682
-42,635
-6% -$3.51M
SWAV
7
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$52.6M 4.03%
161,484
+41,861
+35% +$10.3M
NEO icon
8
NeoGenomics
NEO
$2.43B
$51.9M 3.97%
3,302,165
-624,591
-16% -$9.64M
IRTC icon
9
iRhythm Holdings
IRTC
$3.69B
$48.8M 3.74%
420,892
+268,829
+177% +$30.2M
FNA
10
DELISTED
Paragon 28, Inc.
FNA
$47M 3.6%
3,802,968
-14,826
-0.4% -$176K
TCMD icon
11
Tactile Systems Technology
TCMD
$510M
$42.9M 3.29%
2,641,975
-217,979
-8% -$3.29M
ATRC icon
12
AtriCure
ATRC
$2.86B
$42.1M 3.22%
1,382,860
+33,417
+2% +$1.12M
SIBN icon
13
SI-BONE Inc
SIBN
$831M
$40.5M 3.1%
2,473,165
-74,227
-3% -$1.4M
RARE icon
14
Ultragenyx Pharmaceutical
RARE
$1.29B
$36.9M 2.83%
790,446
+45,781
+6% +$2.16M
CNTA
15
DELISTED
Centessa Pharmaceuticals
CNTA
$33.9M 2.6%
+3,002,045
New +$28.4M
RCM
16
DELISTED
R1 RCM Inc. Common Stock
RCM
$32.9M 2.52%
2,552,325
+1,736,346
+213% +$20.2M
OSCR icon
17
Oscar Health
OSCR
$10B
$31.3M 2.39%
2,102,554
+1,134,919
+117% +$15.5M
PHLT
18
DELISTED
Performant Healthcare Inc
PHLT
$30.9M 2.37%
10,515,127
+845,017
+9% +$2.41M
INSP icon
19
Inspire Medical Systems
INSP
$2.16B
$30.1M 2.3%
139,951
+51,428
+58% +$10.1M
BCYC
20
Bicycle Therapeutics
BCYC
$257M
$29.7M 2.27%
1,193,051
-357,420
-23% -$7.59M
STVN icon
21
Stevanato
STVN
$5.88B
$26.8M 2.05%
835,985
+106,024
+15% +$3.23M
PODD icon
22
Insulet
PODD
$9.66B
$25.9M 1.99%
+151,264
New +$28.2M
MODN
23
DELISTED
MODEL N, INC.
MODN
$25.5M 1.95%
894,241
-646,467
-42% -$17.1M
AVTR icon
24
Avantor
AVTR
$10.4B
$21.8M 1.67%
850,695
+836,099
+5,728% +$19.9M
PRVA icon
25
Privia Health
PRVA
$2.6B
$21.6M 1.66%
+1,103,601
New +$23.3M
1
2 3 4

Similar funds

AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.65B AUM 18.1% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

First Light Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, First Light Asset Management held 87 positions worth $1.31B, up 5.1% from $1.24B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

First Light Asset Management's Q1 2024 filing shows 12 new, 18 increased, 18 reduced and 37 closed positions. Its largest new stake was Centessa Pharmaceuticals: 3,002,045 shares worth $33.9M. The largest sale was Karuna Therapeutics, Inc. Common Stock, an estimated $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials and Communication Services.

  • First Light Asset Management's largest Q1 2024 buy was Centessa Pharmaceuticals: 3,002,045 shares worth $33.9M.
  • First Light Asset Management added most to Natera in Q1 2024, an estimated $36.9M increase.
  • First Light Asset Management's biggest Q1 2024 reduction was Prothena Corp, cutting an estimated $19.2M.
  • First Light Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $90.9M.
  • First Light Asset Management's ten largest holdings make up 44% of its $1.31B portfolio in Q1 2024.
  • First Light Asset Management opened 12 new positions and closed 37 in Q1 2024.
  • First Light Asset Management's portfolio value rose 5.1% quarter-over-quarter to $1.31B.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.